65--MUSKOGEE Blood & Blood Products - 1 Year

. COMBINED SYNOPSIS/SOLICITATION FOR COMMERCIAL ITEMS General Information Document Type: Combined Solicitation/Synopsis Document Title: Muskogee VA Medical Center Blood & Blood Products Solicitation Number: VA259-17-Q-0600 Posted Date: September 11, 2017 Original Response Date: September 15, 2017 Current Response Date: September 15, 2017 Classification Code: 65 Set Aside: Unrestricted NAICS Code: 621991 Contracting Office Address Department of Veterans Affairs Network Contracting Office NCO 19 6162 S. Willow Dr., Ste 300 Greenwood Village, CO 80111 Place of Performance Muskogee VA Medical Center 1011 Honor Heights Drive Muskogee, OK 74401 Description This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in Federal Acquisition Regulation (FAR) subpart 12.6, Streamlined Procedures for Evaluation and Solicitation for Commercial Items, as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; quotations are being requested, and a written solicitation document will not be issued. This solicitation is a request for quotations (RFQ). The solicitation document and incorporated provisions and clauses are those in effect through Federal Acquisition Circular FAC 2005-95 01/19/2017. The associated North American Industrial Classification System (NAICS) code for this procurement is 621991, with a small business size standard of $32.5 Million. The Muskogee VA Medical Center is seeking to purchase Blood & Blood Products. The purpose of this acquisition is to provide Muskogee VA Medical Center with the supplies listed in the Requirements and included CLIN list. This will ensure that the VA Medical Center has an established resource readily available and to prevent future emergency requests, thus decreasing the possibility of delays in patient care. All interested offerors shall provide quotation(s) for the following: CLIN ITEM NUMBER DESCRIPTION OF SUPPLIES/SERVICES QUANTITY UNIT UNIT PRICE AMOUNT 0001 16B - LPC Contract Period: Base POP Begin: 10-01-2017 POP End: 09-30-2018 1,500.00 EA __________________ __________________ 0002 16I - LPC-irrad Contract Period: Base POP Begin: 10-01-2017 POP End: 09-30-2018 5.00 EA __________________ __________________ 0003 61 - Plat (full dose) Contract Period: Base POP Begin: 10-01-2017 POP End: 09-30-2018 100.00 EA __________________ __________________ 0004 61I - Plat (full dose) irrad Contract Period: Base POP Begin: 10-01-2017 POP End: 09-30-2018 2.00 EA __________________ __________________ 0005 62 - Plat-HLA typed Contract Period: Base POP Begin: 10-01-2017 POP End: 09-30-2018 1.00 EA __________________ __________________ 0006 63 - Plat (half dose) Contract Period: Base POP Begin: 10-01-2017 POP End: 09-30-2018 1.00 EA __________________ __________________ 0007 98 - Irradiation Fee Contract Period: Base POP Begin: 10-01-2017 POP End: 09-30-2018 5.00 EA __________________ __________________ 0008 42HR - Fresh Frozen Plasma (FFP) Contract Period: Base POP Begin: 10-01-2017 POP End: 09-30-2018 50.00 EA __________________ __________________ 0009 44PD10 - Cryo (pooled) 10PK Contract Period: Base POP Begin: 10-01-2017 POP End: 09-30-2018 2.00 EA __________________ __________________ 0010 01A - ABO/Rh Contract Period: Base POP Begin: 10-01-2017 POP End: 09-30-2018 50.00 EA __________________ __________________ 0011 02A - DAT Contract Period: Base POP Begin: 10-01-2017 POP End: 09-30-2018 100.00 EA __________________ __________________ 0012 04A - AB Id (cold panel) Contract Period: Base POP Begin: 10-01-2017 POP End: 09-30-2018 2.00 EA __________________ __________________ 0013 04B - AB Id Contract Period: Base POP Begin: 10-01-2017 POP End: 09-30-2018 10.00 EA __________________ __________________ 0014 04E - Antibody Identification Contract Period: Base POP Begin: 10-01-2017 POP End: 09-30-2018 5.00 EA __________________ __________________ 0015 04F - Additional RBC Panel Contract Period: Base POP Begin: 10-01-2017 POP End: 09-30-2018 50.00 EA __________________ __________________ 0016 12B - Compatibility Test Contract Period: Base POP Begin: 10-01-2017 POP End: 09-30-2018 75.00 EA __________________ __________________ 0017 14 - CMV Testing Contract Period: Base POP Begin: 10-01-2017 POP End: 09-30-2018 1.00 EA __________________ __________________ 0018 EXT - Ext of DNA for RBC Contract Period: Base POP Begin: 10-01-2017 POP End: 09-30-2018 5.00 EA __________________ __________________ 0019 FY1 - FY(a) Contract Period: Base POP Begin: 10-01-2017 POP End: 09-30-2018 20.00 EA __________________ __________________ 0020 FY2 - FY(b) Contract Period: Base POP Begin: 10-01-2017 POP End: 09-30-2018 5.00 EA __________________ __________________ 0021 JK1 - Jk(a) Contract Period: Base POP Begin: 10-01-2017 POP End: 09-30-2018 60.00 EA __________________ __________________ 0022 JK2 - Jk(b) Contract Period: Base POP Begin: 10-01-2017 POP End: 09-30-2018 1.00 EA __________________ __________________ 0023 K1 - K Contract Period: Base POP Begin: 10-01-2017 POP End: 09-30-2018 10.00 EA __________________ __________________ 0024 L03 - Antibody Screen Contract Period: Base POP Begin: 10-01-2017 POP End: 09-30-2018 40.00 EA __________________ __________________ 0025 L04 - Antibody ID Contract Period: Base POP Begin: 10-01-2017 POP End: 09-30-2018 40.00 EA __________________ __________________ 0026 L08 - After Hours Tech Fee Contract Period: Base POP Begin: 10-01-2017 POP End: 09-30-2018 10.00 EA __________________ __________________ 0027 L13 - DTT Contract Period: Base POP Begin: 10-01-2017 POP End: 09-30-2018 10.00 EA __________________ __________________ 0028 L14 - DTT Treatment of RBC Contract Period: Base POP Begin: 10-01-2017 POP End: 09-30-2018 15.00 EA __________________ __________________ 0029 L30 - Blood Comp Prep Contract Period: Base POP Begin: 10-01-2017 POP End: 09-30-2018 20.00 EA __________________ __________________ 0030 L31 - Sample Resubmission Fee Contract Period: Base POP Begin: 10-01-2017 POP End: 09-30-2018 1.00 EA __________________ __________________ 0031 LE1 - LEA Antigen Type Contract Period: Base POP Begin: 10-01-2017 POP End: 09-30-2018 1.00 EA __________________ __________________ 0032 LE2 - LEB Antigen Type Contract Period: Base POP Begin: 10-01-2017 POP End: 09-30-2018 1.00 EA __________________ __________________ 0033 MS1 - M Antigen Type Contract Period: Base POP Begin: 10-01-2017 POP End: 09-30-2018 1.00 EA __________________ __________________ 0034 MS2 - N Antigen Type Contract Period: Base POP Begin: 10-01-2017 POP End: 09-30-2018 1.00 EA __________________ __________________ 0035 MS3 - S Antigen Type Contract Period: Base POP Begin: 10-01-2017 POP End: 09-30-2018 1.00 EA __________________ __________________ 0036 MS4 - S Antigen Type Contract Period: Base POP Begin: 10-01-2017 POP End: 09-30-2018 1.00 EA __________________ __________________ 0037 P1 - P1 Antigen Type Contract Period: Base POP Begin: 10-01-2017 POP End: 09-30-2018 1.00 EA __________________ __________________ 0038 RH2 - C Antigen Type Contract Period: Base POP Begin: 10-01-2017 POP End: 09-30-2018 20.00 EA __________________ __________________ 0039 RH3 - E Antigen Type Contract Period: Base POP Begin: 10-01-2017 POP End: 09-30-2018 10.00 EA __________________ __________________ 0040 RH4 - C Antigen Type Contract Period: Base POP Begin: 10-01-2017 POP End: 09-30-2018 1.00 EA __________________ __________________ 0041 RH5 - E Antigen Type Contract Period: Base POP Begin: 10-01-2017 POP End: 09-30-2018 1.00 EA __________________ __________________ 0042 OTH - Rare Anti-Sera Contract Period: Base POP Begin: 10-01-2017 POP End: 09-30-2018 1.00 EA __________________ __________________ 0043 RMT - RBC Molecular Typing Contract Period: Base POP Begin: 10-01-2017 POP End: 09-30-2018 5.00 EA __________________ __________________ GRAND TOTAL __________________ Credit at the rate of $_____ will be allowed for Packed Cells Leukoreduced returned within ____ day(s) remaining until expiration date. Credit at the rate of $_____ will be allowed for Platelets Pheresis returned within ____ days(s) remaining until expiration date. Credit at the rate of $_____ (Red Blood Cells Leukoreduced) and $_____ (Platelets Pheresis) will be allowed for short dated products approved for return/transfer at dates later than those listed above. Credit at the rate of $_____ will be allowed for each unit collected during Vendor Blood Drives held at facility. Credit at the rate of $_____ will be allowed for Fresh Frozen Plasma returned within ____ day(s) remaining until expiration date. Credit at the rate of $_____ will be allowed for Cryoprecipitate (CRYO) returned within ____ day(s) remaining until expiration date. Credit at the rate of $_____ will be allowed for any AB Typed units returned, regardless of expiration date. REQUIREMENTS A. GENERAL INFORMATION 1. Requirements: The contractor shall provide all resources necessary to accomplish the deliverables described in this document, except as may otherwise be specified. You will be required to furnish Blood and Blood Products to the Jack C Montgomery VA Medical Center (JCMVAMC), 1011 Honor Heights Drive, Muskogee, Ok 74401, in accordance with the terms and conditions of the contract. 2. Background: The awarding contractor will be required to furnish Blood and Blood Products to the JCMVAMC, in accordance with the terms and conditions of the contract, for estimated quantities and procedures listed. 3. A Point of Contact (POC) will be designated to act for the Contracting Officer in determining compliance with the contract and accepting or rejecting invoices submitted based on work performance. GENERAL REQUIREMENTS 1. The contractor will furnish all personnel, supplies and facilities necessary to collect, process, store and deliver human blood components and derivatives. The blood bank must currently be registered and/or licensed with the Food and Drug Administration (FDA), Department of Health and Human Services pursuant to Section 510 of the Federal Food, Drug, and Cosmetic Act, as amended. 21 USC Section 260. 2. The contractor must submit proof, upon request, that they hold an unrevoked U.S. License which is issued by the Director of Biologics, Food and Drug Administration (FDA) under Section 351 of the Public Health Service Act, as amended, 42 USC Section 262, as a source of supply for whole blood. 3. Specimen and blood components must be transported/shipped is such a way to ensure the integrity of specimens and blood components, and comply with accreditation standards and requirements as defined by FDA and American Association of Blood Banks (AABB). If interstate shipment of blood or blood component is involved, the contractor must submit with the offer a statement that such approval has been authorized under Public Health Service Act 351, as amended, 42 USC Section 62. 4. Contractor will provide human blood components only from volunteer donors in accordance with the latest FDA regulations. A volunteer donor is a person who does not receive monetary payment for blood donations. The contractor must maintain readily available blood donor lists including names, addresses, and Social Security numbers. Such lists should indicate whether, and on what date, blood of a particular donor was furnished to JCMVAMC under this contract. Donor selection must be accordance with criteria established by the FDA and the AABB. The contractor certifies that he will comply with the donor requirements with respect to donors, containers, delivery, etc. 5. All written deliverables shall be phrased in layperson language. Statistical and other technical terminology shall not be used without providing a glossary of terms. 6. The VA reserves the right to inspect the contracted facility at any time. The VA shall notify the contractor in advance of anticipated inspections. The POC shall inspect the blood and has the authority to inspect quality, quantity, and verify adherence to the technical and delivery requirements of the contract. The JCMVAMC will retain all such information viewed and obtained during the audits as confidential. 7. The POC for JCMVAMC is Jana Burk, Blood Bank Supervisor, +1 (555) 000-0000 or +1 (555) 000-0000. D. SPECIFIC MANDATORY TASKS AND ASSOCIATED DELIVERABLES Description of Tasks and Associated Deliverables: The contractor shall provide the specific deliverables described below within the performance period. Once a contract is awarded, the requirements for the contractor shall not be changed in any way whatsoever by anyone other than the CO. 1. All blood components will be tested according to the current edition of the American Association of Blood Banks (AABB) standards. This testing will include, but is not limited to the following: (a) ABO Group (b) Rh type, a test for weak D when the initial test with Anti-D is negative (c ) A test for clinically significant antibodies, when appropriate 2. All blood components will be tested and found to be negative for HBsAg, Anti-HBc, anti-HTLV, HIV-1 Ag, anti-HIV, anti-HIV-2, anti-HCV, HIV/HCV, and WNV by NAT and a serological test for syphilis. In the event that FDA or the AABB requires additional testing, these tests will also be performed. 3. All blood components will be collected from volunteer donors and will be processed according to FDA (Food and Drug Administration) and AABB regulations. 4. All blood is to be collected by the closed system under aseptic conditions and Plasma is prepared and frozen under conditions and procedures mandated by FDA and required by AABB. All blood supplied shall be grossly free of hemolysis, excessive chyle and clots. In addition, all Fresh Frozen Plasma shall have been tested negatively utilizing Nucleic Acid Testing (NAT) for Human Immunodeficiency Virus (HIV) and Hepatitis C virus prior to shipment. Assigned expiration dates for all blood components are to comply with 21CFR 610.53 and the manufacturer s recommendations. 5. The contractor will supply the VA with assurance of the following: (a) Traceability of all products from collection to delivery (b) Quality Control (QC) procedures and the contractor shall make QC data available for review. (c) Quality Management systems are in place (d) Current good manufacturing practices are followed 6. The contractor shall have the following licenses and or registration and shall make them available for review by the VA: (a) The contractor shall maintain an unrevoked U.S. license which is issued by the Director, Bureau of Biologics, FDA under section 351 of the Public Health Service Act, as amended, 42 USC Section 262, as a source of supply for whole blood. (b) If the contractor is involved in interstate shipment of blood or blood components, the contractor must maintain approval authorized under Section 251 of the Public Health Service Act, as amended, 42 USC Section 262. (c) The contractor s Blood Bank must maintain registration and/or licensing with the Food and Drug Administration (FDA), Department of Health and Human Services pursuant to Section 510 of the Federal Food and Drug Cosmetic Act, as amended, 21 USC Section 260 at all times during the contract period. (d) Certificate of Accreditation under the Clinical Laboratory Improvement Act of 1988 or current certification by the College of American Pathologists. 7. The contractor shall deliver the components under storage conditions as required by FDA and AABB regulations and standards. 8. Red blood cells delivered shall have a dating period of one (1) week or more from the date of delivery. 9. Platelet Apheresis delivered shall have a dating period of one (1) to four (4) days from date of delivery. Platelet Apheresis products with less than one (1) day may be provided, upon approval by JCMVAMC. 10. Cryoprecipitate and Fresh frozen plasma shall have a dating period of at least sixty (60) days from the date of delivery. Any breakage or leakage during thawing will be replaced or credit given to JCMVAMC. 11. All blood components will be labeled using ISBT labeling as to A, B, O, and Rh type, unit identification number, product code, expiration date, and CMV negative if applicable. 12. As per FDA requirements: Immediately after bleeding, the blood shall be refrigerated between 1-6 °C with fluctuation of no more than 2°C within this range. Freezing must be avoided at all times. If public transportation of blood is necessary it shall be transported in clean shipping containers provided with refrigeration sufficient to hold the blood at 1-10°C if it has been cooled. If the blood has not been cooled the shipping containers shall provide sufficient refrigeration to bring the temperature toward 1-10°C preferably 1-6°C while in transit. 13. As per FDA requirements: Immediately after bleeding, the platelets shall rest for 3 hours and then placed on shaker until processed, then stored between 20-24°C with continuous rocking with fluctuation of no more than 2°C within this range. Refrigeration and freezing must be avoided at all times. If public transportation of platelets is necessary it shall be transported in clean shipping containers provided with temperatures sufficient to hold the platelets at 20-24°C while in transit. 14. As per FDA requirements: Immediately after bleeding, the cryoprecipitate shall be prepared by a method known to separate the cold insoluble portion from fresh frozen plasma and be frozen at a temperature of <-18°C within 24 hours of collection. If public transportation of cryoprecipitate is necessary it shall be transported in clean shipping containers provided with temperature sufficient to hold the cryoprecipitate at <-18°C while in transit. 15. As per FDA requirements: Immediately after bleeding, the fresh frozen plasma shall be prepared by a method known to separate the plasma from whole blood and be frozen at a temperature of <-18°C within 24 hours of collection. If public transportation of fresh frozen plasma is necessary it shall be transported in clean shipping containers provided with temperature sufficient to hold the fresh frozen plasma at <-18°C while in transit. 16. JCMVAMC shall promptly report to the contractor any possible infectious disease or other serious complication associated with the transfusions which may have resulted from any blood provided by the contractor, included suspected post-transfusion Hepatitis, transfusion-associated HIV or HTLV infection, and any other transfusion-associated infections (malaria, babesiosis, bacterial contamination or infection) and death. JCMVAMC shall cooperate with the contractors investigation of any and all such diseases or complications and supply to contractor in confidence information concerning the recipient of the blood, upon forms provided by contractor, to the extent permissible under the laws applicable to patient confidentiality. JCMVAMC shall maintain complete and accurate records of patients supplied with blood (including product names, lot identificaitons, and quantities), and therapeutic adverse effects, complaints, or other pertinent information relating to blood. 17. JCMVAMC acknowledges the results of tests performed by the contractor cannot be guaranteed by the contractor and occurrences of some errors (either false positives, or false negatives) cannot be eliminated due to the nature of the tests. Contractor cannot and does not guarantee the blood products or services in any way. In no event is the contractor responsible for any loss or damage arising out of the defective or incorrect blood products or services unless attributable to contractor s gross negligence or willful misconduct. Notwithstanding anything herein to the contrary in no event shall the contractor be liable or responsible to JCMVAMC or to the any of the JCMVAMCs patients for the unavailability of blood products or services either in the quantity requested or at the time specified, provided the contractor has made reasonable efforts to provide such blood products or services. This clause shall supersede and replace Section 52-212-4 (o) of the solicitation as permitted by FAR Clause 12-302. E. SCHEDULE FOR DELIVERABLES 1. If for any reason any deliverable cannot be delivered within the scheduled time frame, the contractor is required to explain why in writing to the POC, including a firm commitment of when the work shall be completed. This notice to the POC shall cite the reasons for the delay, and the impact on the overall project. The POC will then review the facts and issue a response, in accordance with applicable regulations. 2. All deliverables shall be made to the Blood Bank within JCMVAMC premises. Contractor agrees to deliver supplies and/or services that are requested by JCMVAMC on a 24-hours, 7-day week availability regardless of Federal Holidays. Deliveries designated as routine shall not carry additional charges. Additional charges may be applied for after-hour services. 3. The contractor will supply the Blood Bank with a minimum estimated inventory of Leuko-depleted Red Blood Cells, Cryoprecipitate and Fresh Frozen Plasma (FFP) as follows: LEUKO-Depleted RED BLOOD CELLS O Positive 12-16 units A Positive 12-16 units AB Positive 4 units B Positive 4-6 units A Negative 4-6 units O Negative 4-6 units B Negative as needed AB Negative as needed FFP O 4-6 units A 4-6 units B 4 units AB 4 units CRYOPRECIPITATE O 2 units 4. The contractor will supply the Blood Bank with Platelet Apheresis with a minimum inventory as needed. Platelets will not be kept on hand at JCMVAMC but rather ordered as needed. 5. Routine deliveries of blood/blood products will be a minimum of 2 to 3 times a week. Each morning the blood bank technologist will review all blood/blood product inventory for routine stock needs and special order needs. The technologist will enter routine order/orders into Blood Hub for routine scheduled delivery. 6. Routine deliveries for blood/blood products not included above shall be delivered within 8 hours of request. ASAP and STAT requests for these items shall be processed within one (1) hour of the order and delivered within one and half (1-1/2) hours of processing. 7. Deliveries shall be made to the JCMVAMC, 1011 Honor Heights Drive, Muskogee, OK 74401, Pathology & Laboratory Medicine Service, Room 2C-52H. 8. The contractor must allow for credit of units with a minimum of 7 days prior to expiration date. Credit can be applied if the contractor allows this facility to hold units until they expire, then these units will be either destroyed according to FDA regulations or returned to the contractor. An invoice will be sent to contractor for reference of credit. 9. The contractor must allow credit of units transferred to another facility using the same contractor to cover emergency needs of the requesting facility. 10. Items requiring Emergency Reference Laboratory Services shall be picked up within one (1) hour of the request, services started within two (2) hours of pickup and returned within one (1) hour of completion of tests or the results provided to JCMVAMC within one (1) hour of completion of test. After hour charges may be charged when the VA requests services before 08:00am or after 4:30pm on any working day or any time on nonworking days. Working days are Monday-Friday excluding official Federal Holidays. 11. Payment will be made promptly upon receipt and certification of a proper invoice at the designated payment office. A detailed invoice shall list the total quantities of each product or service provided or credited during a particular month, including date, description, amounts, and quantity with appropriate referenced CLIN. Invoices shall also be sent via mail, email or both to: Jack C Montgomery VA Medical Center Attention: Jana Burk Blood Bank (113) 1011 Honor Heights Drive Muskogee, OK 74401 Email: contact@example.gov 12. By the 10th of each month, the contractor shall provide the POC the totals of items and services used during the preceding calendar month using the item numbers and descriptions exactly as they are listed in the contract. 13. The schedule of supplies/services represents estimated requirements of JCMVAMC. JCMVAMC will be obligated to pay for only those items and/or services ordered and received. F. QUALITY MONITOR FOR DELIVERABLES 1. All blood/blood products will be inspected upon receipt from the supplier. If the blood/blood products are found to be unacceptable they will be rejected by JCMVAMC and returned to supplier. Inspection will include the following: a. Abnormal color and appearance b. Proper labeling and shipping conditions to include: 1. Unit number 2. Product Code 3. ABO/Rh 4. Expiration date 5. CMV negative or Antigen negative (if applicable) 6. Condition of coolant c. Bag integrity, hemolysis, and clots d. Segments and ports for adequate sealing or closure ANNUAL SCHEDULE OF SUPPLIES/SERVICE Item No Test Unit Minimum Quantity Estimated Quantity 16B LPC EA 1,000 1,500 16I LPC-irrad EA 1 5 61 Plat (full dose) EA 50 100 61I Plat (full dose) irrad EA 1 2 62 Plat-HLA typed EA 0 1 63 Plat (half dose) EA 0 1 98 Irradiation fee EA 0 5 42HR Fresh Frozen Plasma EA 25 50 44PD10 Cryo (pooled) 10 pk EA 2 2 01A ABO/Rh EA 10 50 02A DAT EA 50 100 04A AB Id (cold panel) EA 0 2 04B AB Id EA 1 10 04E Antibody Identification EA 1 5 04F Addt'l RBC Panel EA 10 50 12B Compatibility Test EA 50 75 14 CMV Testing EA 0 1 EXT Ext of DNA for RBC EA 1 5 FY1 FY(a) EA 1 20 FY2 FY(b) EA 0 5 JK1 Jk(a) EA 1 60 JK2 Jk(b) EA 0 1 K1 K EA 1 10 L03 Antibody Screen EA 10 40 L04 Antibody ID EA 10 40 L08 After Hours Tech Fee EA 5 10 L13 DTT EA 1 10 L14 DTT Treatment of RBC EA 1 15 L30 Blood Comp Prep EA 5 20 L31 Sample Resubmission Fee EA 0 1 LE1 LEA Antigen Type EA 0 1 LE2 LEB Antigen Type EA 0 1 MS1 M Antigen Type EA 0 1 MS2 N Antigen Type EA 0 1 MS3 S Antigen Type EA 0 1 MS4 S Antigen Type EA 0 1 P1 P1 Antigen Type EA 0 1 RH2 C Antigen Type EA 1 20 RH3 E Antigen Type EA 1 10 RH4 C Antigen Type EA 0 1 RH5 E Antigen Type EA 0 1 OTH Rare Anti-sera EA 0 1 RMT RBC Molecular Typing EA 0 5 The full text of FAR provisions or clauses may be accessed electronically at http://acquisition.gov/comp/far/index.html or http://farsite.hill.af.mil/. The following solicitation provisions apply to this acquisition: FAR 52.209-5, Representation by Corporations Regarding an Unpaid Tax Liability or a Felony Conviction under Any Federal Law (Mar 2012) (Deviation). FAR 52.212-1, Instructions to Offerors Commercial Items (Jan 2017) FAR 52.212-3, Offerors Representations and Certifications Commercial Items (Jan 2017) VAAR 852.215-70, Service-Disabled Veteran-Owned and Veteran-Owned Small Business Evaluation Factors (Jul 2016) (Deviation) Offerors must complete annual representations and certifications on-line at http://orca.bpn.gov in accordance with FAR 52.212-3, Offerors Representations and Certifications Commercial Items. If paragraph (j) of the provision is applicable, a written submission is required. The following contract clauses apply to this acquisition: FAR 52.212-4, Contract Terms and Conditions Commercial Items (Jan 2017) FAR 52.212-5, Contract Terms and Conditions Required to Implement Statutes or Executive Orders (Jan 2017) The following subparagraphs of FAR 52.212-5 are applicable: Subparagraph (b)(1), (b)(2), (b)(4), (b)(6), (b)(7), (b)(8), (b)(9), (b)(25), (b)(27), (b)(28), (b)(29), (b)(30),(b)(31), (b)(32), (b)(33), (b)(34), (b)(35), (b)(42), (b)(48), (b)(54), (b)(57), (c)(1), (c)(2), (c)(4), (c)(8). FAR 52.217-8, Option to Extend Services (Nov 1999) FAR 52.232-19, Availability of Funds for the Next Fiscal Year (Apr 1984) VAAR 852.203-70, Commercial Advertising (Jan 2008) VAAR 852.215-71, Evaluation Factor Commitments (Dec 2009) All offerors shall submit the following: (1) copy of the CLIN list completed with unit price, (1) copy of 52.209-5, Representation by Corporations Regarding an Unpaid Tax Liability or a Felony Conviction under Any Federal Law filled out (attached for convenience), and provide their DUNS. All quotations shall be sent via email to contact@example.gov. This is an open-market combined synopsis/solicitation for supplies as defined herein. - The government intends to award a Firm-Fixed-Price award in response to this combined synopsis/solicitation that will include the terms and conditions set forth herein. To facilitate the award process, all quotes must include a statement regarding the terms and conditions herein as follows: "The terms and conditions in the solicitation are acceptable to be included in the award document without modification, deletion, or addition." OR "The terms and conditions in the solicitation are acceptable to be included in the award document with the exception, deletion, or addition of the following:" Offeror shall list exception(s) and rationale for the exception(s). Submission shall be received not later than September 15, 2017 at 1700 MST at via email to contact@example.gov. Late submissions shall be treated in accordance with the solicitation provision at FAR 52.212-1(f). Any questions or concerns regarding this solicitation should be forwarded in writing via e-mail to the Contract Specialist Sura-Quay Arbon at contact@example.gov. Point of Contact Contract Specialist Sura-Quay Arbon at contact@example.gov. Attachments